Human Adiponectin FlowCytomix Simplex

Description: This FlowCytomix Simplex Kit is designed for the measurement of Human Adiponectin in an immunoassay analyzed on a flow cytometer. Together with the FlowCytomix Human Basic Kit (cat. BMS8420FF), this kit can be used to detect Adiponectin alone or can be multiplexed with other Simplex Kits to measure a variety of analytes.

This kit contains bead population B7.

Adiponectin is a protein hormone that modulates a number of metabolic processes, including glucose regulation and fatty acid catabolism. Adiponectin is exclusively secreted from adipose tissue into the bloodstream and is very abundant in plasma relative to many hormones. The hormone plays a role in the suppression of the metabolic derangements that may result in type 2 diabetes, obesity, atherosclerosis and non-alcoholic fatty liver disease (NAFLD).
Adiponectin is secreted into the bloodsteam where it accounts for approximately 0.01% of all plasma protein. Plasma concentrations reveal a sexual dimorphism, with females having higher levels than males. Levels of adiponectin are reduced in diabetics compared to non-diabetics. Weight reduction significantly increases circulating levels.
Adiponectin automatically self-associates into larger structures. Adiponectin binds to a number of receptors. So far, two receptors have been identified, with homology to G protein-coupled receptors.
Adiponectin exerts some of its weight reduction effects via the brain. This is similar to the action of leptin, but the two hormones perform complementary actions, and can have additive effects. Adiponectin affects glucose flux (gluconeogenesis, glucose uptake), lipid catabolism (beta-oxidation, triglyceride clearance), endothelial dysfunction, insulin sensitivity and weight loss.
Administration of Adiponectin remains a promising area of research for clinical therapy in diseases such as obesity, type 2 diabetes and fatty liver disease.

References: Oh,D.K.; Ciaraldi,T.; Henry,R.R.. Adiponectin in health and disease. Diabetes Obes.Metab 2007;9:282-289. (Link)

Hara,K.; Yamauchi,T.; Kadowaki,T.. Adiponectin: an adipokine linking adipocytes and type 2 diabetes in humans. Curr.Diab.Rep. 2005;5:136-140. (Link)

Barb,D.; Pazaitou-Panayiotou,K.; Mantzoros,C.S.. Adiponectin: a link between obesity and cancer. Expert.Opin.Investig.Drugs 2006;15:917-931. (Link)

Do,D.; Alvarez,J.; Chiquette,E.; Chilton,R.. The good fat hormone: adiponectin and cardiovascular disease. Curr.Atheroscler.Rep. 2006;8:94-99. (Link)

Hopkins,T.A.; Ouchi,N.; Shibata,R.; Walsh,K.. Adiponectin actions in the cardiovascular system. Cardiovasc.Res. 2007;74:11-18. (Link)

Nishida,M.; Funahashi,T.; Shimomura,I.. Pathophysiological significance of adiponectin. Med.Mol Morphol. 2007;40:55-67. (Link)

Ahima,R.S.. Metabolic actions of adipocyte hormones: focus on adiponectin. Obesity.(Silver.Spring) 2006;14 Suppl 1:9S-15S. (Link)

Mendez-Sanchez,N.; Chavez-Tapia,N.C.; Zamora-Valdes,D.; Uribe,M.. Adiponectin, structure, function and pathophysiological implications in non-alcoholic fatty liver disease. Mini.Rev.Med.Chem. 2006;6:651-656. (Link)

Lafontan,M.; Viguerie,N.. Role of adipokines in the control of energy metabolism: focus on adiponectin. Curr.Opin.Pharmacol. 2006;6:580-585. (Link)

Whitehead,J.P.; Richards,A.A.; Hickman,I.J.; Macdonald,G.A.; Prins,J.B.. Adiponectin--a key adipokine in the metabolic syndrome. Diabetes Obes.Metab 2006;8:264-280. (Link)

Brooks,N.L.; Moore,K.S.; Clark,R.D.; Perfetti,M.T.; Trent,C.M.; Combs,T.P.. Do low levels of circulating adiponectin represent a biomarker or just another risk factor for the metabolic syndrome?. Diabetes Obes.Metab 2007;9:246-258. (Link)

Menzaghi,C.; Trischitta,V.; Doria,A.. Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes 2007;56:1198-1209. (Link)

Han,S.H.; Quon,M.J.; Kim,J.A.; Koh,K.K.. Adiponectin and cardiovascular disease: response to therapeutic interventions. J.Am.Coll.Cardiol. 2007;49:531-538. (Link)

Nedvidkova,J.; Smitka,K.; Kopsky,V.; Hainer,V.. Adiponectin, an adipocyte-derived protein. Physiol Res. 2005;54:133-140. (Link)

Lihn,A.S.; Pedersen,S.B.; Richelsen,B.. Adiponectin: action, regulation and association to insulin sensitivity. Obes.Rev. 2005;6:13-21. (Link)

Goldstein,B.J.; Scalia,R.. Adiponectin: A novel adipokine linking adipocytes and vascular function. J.Clin.Endocrinol.Metab 2004;89:2563-2568. (Link)

Lara-Castro,C.; Fu,Y.; Chung,B.H.; Garvey,W.T.. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr.Opin.Lipidol. 2007;18:263-270. (Link)